The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic-Resistant Gram-Negative Bacteria
Open accessAbstract
Determination of the attributable hospital cost and length of stay (LOS) are of critical importance for patients, providers, and payers who must make rational and informed decisions about patient care and the allocation of resources. The objective of the present study was to determine the additional total hospital cost and LOS attributable to health care-associated infections (HAIs) caused by antibiotic-resistant, gram-negative (GN) pathogens. A single-center, retrospective, observational comparative cohort study was performed. The study involved 662 patients admitted from 2000 to 2008 who developed HAIs caused by one of following pathogens:Acinetobacter spp.,Enterobacter spp.,Escherichia coli,Klebsiella spp., or Pseudomonas spp. The attributable total hospital cost and LOS for HAIs caused by antibiotic-resistant GN pathogens were determined by comparison with the hospital costs and LOS for a control group with HAIs due to antibiotic-susceptible GN pathogens. Statistical analyses were conducted by using univariate and multivariate analyses. Twenty-nine percent of the HAIs were caused by resistant GN pathogens, and almost 16% involved a multidrug-resistant GN pathogen. The additional total hospital cost and LOS attributable to antibiotic-resistant HAIs caused by GN pathogens were 29.3% (P< 0.0001; 95% confidence interval, 16.23 to 42.35) and 23.8% (P= 0.0003; 95% confidence interval, 11.01 to 36.56) higher than those attributable to HAIs caused by antibiotic-susceptible GN pathogens, respectively. Significant covariates in the multivariate analysis were age ≥12 years, pneumonia, intensive care unit stay, and neutropenia. HAIs caused by antibiotic-resistant GN pathogens were associated with significantly higher total hospital costs and increased LOSs compared to those caused by their susceptible counterparts. This information should be used to assess the potential cost-efficacy of interventions aimed at the prevention of such infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002
Klevens, R. M., Edwards, J. R., Richards, C. L., Horan, T. C., Gaynes, R. P., Pollock, D. A., & Cardo, D. M. (2007) · Public Health Reports® · doi:10.1177/003335490712200205 · Cited by 2,960
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
System, A. R. F. T. N. (2004) · American Journal of Infection Control · doi:10.1016/j.ajic.2004.10.001 · Cited by 2,342
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,310
Spellberg, B., Guidos, R., Gilbert, D., Bradley, J., Boucher, H. W., Scheld, W. M., Bartlett, J. G., Edwards, J., & the Infectious Diseases Society of America (2008) · Clinical Infectious Diseases · doi:10.1086/524891 · Cited by 1,642
Overview of Nosocomial Infections Caused by Gram-Negative Bacilli
Weinstein, R. A., Gaynes, R., Edwards, J. R., & System, N. N. I. S. (2005) · Clinical Infectious Diseases · doi:10.1086/432803 · Cited by 1,404
An overview of nosocomial infections, including the role of the microbiology laboratory
Emori, T. G., & Gaynes, R. P. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.4.428 · Cited by 1,286
Cosgrove, S. E. (2006) · Clinical Infectious Diseases · doi:10.1086/499406 · Cited by 1,271
A positive fluid balance is associated with a worse outcome in patients with acute renal failure
Payen, D., de Pont, A. C., Sakr, Y., Spies, C., Reinhart, K., & Vincent, J. L. (2008) · Critical Care · doi:10.1186/cc6916 · Cited by 962
Engemann, J. J., Carmeli, Y., Cosgrove, S. E., Fowler, V. G., Bronstein, M. Z., Trivette, S. L., Briggs, J. P., Sexton, D. J., & Kaye, K. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367653 · Cited by 934
Resistance in Gram-Negative Bacteria: Enterobacteriaceae
Paterson, D. L. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.013 · Cited by 874
Cosgrove, S. E., Qi, Y., Kaye, K. S., Harbarth, S., Karchmer, A. W., & Carmeli, Y. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502522 · Cited by 856
Lautenbach, E., Patel, J. B., Bilker, W. B., Edelstein, P. H., & Fishman, N. O. (2001) · Clinical Infectious Diseases · doi:10.1086/319757 · Cited by 747
The Impact of Antimicrobial Resistance on Health and Economic Outcomes
Eliopoulos, G. M., Cosgrove, S. E., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/375081 · Cited by 637
Resistance in gram-negative bacteria: Enterobacteriaceae
Paterson, D. L. (2006) · American Journal of Infection Control · doi:10.1016/j.ajic.2006.05.238 · Cited by 535
Schwaber, M. J., Navon-Venezia, S., Kaye, K. S., Ben-Ami, R., Schwartz, D., & Carmeli, Y. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1257-1262.2006 · Cited by 416
Health and Economic Impacts of Antimicrobial Resistance
Holmberg, S. D., Solomon, S. L., & Blake, P. A. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.6.1065 · Cited by 413
Health and Economic Outcomes of Antibiotic Resistance in Pseudomonas aeruginosa
Carmeli, Y., Troillet, N., Karchmer, A. W., & Samore, M. H. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1127 · Cited by 363
Systematic review of economic analyses of health care-associated infections
Stone, P. W., Braccia, D., & Larson, E. (2005) · American Journal of Infection Control · doi:10.1016/j.ajic.2005.04.246 · Cited by 338
Clinical and economic burden of antimicrobial resistance
Maragakis, L. L., Perencevich, E. N., & Cosgrove, S. E. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.751 · Cited by 329
Cosgrove, S. E., Kaye, K. S., Eliopoulous, G. M., & Carmeli, Y. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.2.185 · Cited by 299
Health and Economic Outcomes of Vancomycin-Resistant Enterococci
Carmeli, Y., Eliopoulos, G., Mozaffari, E., & Samore, M. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.19.2223 · Cited by 249
Fluoroquinolone-Resistant Pseudomonas aeruginosa: Assessment of Risk Factors and Clinical Impact
Gasink, L. B., Fishman, N. O., Weiner, M. G., Nachamkin, I., Bilker, W. B., & Lautenbach, E. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.11.029 · Cited by 206
Gram-negative antibiotic resistance: there is a price to pay
Slama, T. G. (2008) · Critical Care · doi:10.1186/cc6820 · Cited by 206
Stone, P. W., Larson, E., & Kawar, L. N. (2002) · American Journal of Infection Control · doi:10.1067/mic.2002.121099 · Cited by 200
Lee, N.-Y., Lee, H.-C., Ko, N.-Y., Chang, C.-M., Shih, H.-I., Wu, C.-J., & Ko, W.-C. (2007) · Infection Control & Hospital Epidemiology · doi:10.1086/517954 · Cited by 198
Shorr, A. F. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e31819ced02 · Cited by 181
Antimicrobial resistance among gram-negative organisms in the intensive care unit
Clark, N. M., PATTERSON, J. E., & Lynch, J. P. (2003) · Current Opinion in Critical Care · doi:10.1097/00075198-200310000-00012 · Cited by 168
Lautenbach, E., Weiner, M., Nachamkin, I., Bilker, W., Sheridan, A., & Fishman, N. (2006) · Infection Control & Hospital Epidemiology · doi:10.1086/507274 · Cited by 159
Lee, S. Y., Kotapati, S., Kuti, J. L., Nightingale, C. H., & Nicolau, D. P. (2006) · Infection Control and Hospital Epidemiology · doi:10.1086/507962 · Cited by 143
Cost of Gram-negative resistance*
Evans, H. L., Lefrak, S. N., Lyman, J. A., Smith, R. L., Chong, T. W., McElearney, S. T., Schulman, A. R., Hughes, M. G., Raymond, D. P., Pruett, T. L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000251496.61520.75 · Cited by 128
Siegel, R. E. (2008) · Respiratory Care · doi:10.4187/respcare.08530471 · Cited by 122
Reference Group Choice and Antibiotic Resistance Outcomes
Kaye, K. S., Engemann, J. J., Mozaffari, E., & Carmeli, Y. (2004) · Emerging infectious diseases · doi:10.3201/eid1006.020665 · Cited by 119
Lim, S. ‐., & Webb, S. A. R. (2005) · Anaesthesia · doi:10.1111/j.1365-2044.2005.04220.x · Cited by 101
The Brooklyn Antibiotic Resistance Task Force (2002) · Infection Control and Hospital Epidemiology · doi:10.1086/502018 · Cited by 90
Howard, D. H., Cordell, R. L., McGowan, J. E., Packard, R. M., Scott, R. D., Solomon, S. L., & the Workshop Group (2001) · Clinical Infectious Diseases · doi:10.1086/323758 · Cited by 80
Rhomberg, P. R., & Jones, R. N. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.07.009 · Cited by 53
Performance of statistical models to predict mental health and substance abuse cost
Montez‐Rath, M. E., Christiansen, C. L., Ettner, S. L., Loveland, S. A., & Rosen, A. K. (2006) · BMC Medical Research Methodology · doi:10.1186/1471-2288-6-53 · Cited by 40
Cited by
Pseudomonas Aeruginosa: Resistance to the Max
Poole, K. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00065 · Cited by 948
Combating Antimicrobial Resistance: Policy Recommendations to Save Lives
Infectious Diseases Society of America (IDSA) (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir153 · Cited by 733
Fishman, N., Society for Healthcare Epidemiology of America, Infectious Diseases Society of America, & Pediatric Infectious Diseases Society (2012) · Infection Control & Hospital Epidemiology · doi:10.1086/665010 · Cited by 677
Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes
Hirsch, E. B., & Tam, V. H. (2010) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.10.49 · Cited by 406
Infections Caused by Resistant Gram‐Negative Bacteria: Epidemiology and Management
Kaye, K. S., & Pogue, J. M. (2015) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1636 · Cited by 383
Metadata
- Authors
- Mauldin, P. D., Salgado, C. D., Hansen, I. S., Durup, D. T., & Bosso, J. A.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2010-01
- Volume
- 54
- Issue
- 1
- Pages
- 109-115
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2102821548
- Cited by
- 360
- References
- 40
- FWCI
- 7.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.